441 results on '"Amerio, Paolo"'
Search Results
2. A Multidisciplinary Approach Is Beneficial in Atopic Dermatitis
3. Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi Consensus
4. 3D TEM and SEM-array tomography of Hailey-Hailey Disease human skin biopsies
5. Italian S3-Guideline on the treatment of Atopic Eczema - Part 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Environmental Dermatology (SIDAPA)
6. Italian S3-Guideline on the treatment of atopic eczema - First Update, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA)
7. Italian S3-Guideline on the treatment of atopic eczema Part 2: non-systemic treatments and treatment recommendations for special AE patient populations, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA)
8. Two Cases of Erythema Annulare Centrifigum Triggered by COVID-19 Vaccination
9. “Sorting hat” flap as a modification of the classic A-T flap
10. Burden of Disease in Real-Life Setting of Patients With Atopic Dermatitis: Italian Data From the MEASURE-AD Study
11. Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations
12. Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis
13. Patients Withdrawing Dupilumab Monotherapy for COVID-19–Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy
14. Patients Withdrawing Dupilumab Monotherapy for COVID-19–Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy
15. Intralesional Methotrexate for the Treatment of Advanced Keratinocytic Tumors: A Multi-Center Retrospective Study
16. Pulsed Radiofrequency Electromagnetic Fields as Modulators of Inflammation and Wound Healing in Primary Dermal Fibroblasts of Ulcers.
17. The Effect of Anxiety on Intraoperative and Postoperative Pain in Patients Undergoing Dermatologic Surgery: Learn to Manage
18. Prurigo‐like atopic dermatitis in a child with CARD11‐associated severe combined immunodeficiency successfully treated with dupilumab
19. Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real‐world study.
20. Clinical and Ultrasonographic Characterization of Hidradenitis Suppurativa in Female Patients: Impact of Early Recognition of the Disease
21. Conventional surgery compared with formalin‐fixed tissue Mohs surgery (slow Mohs) for DFSP: A comparative analysis of 83 cases
22. Insights from a Case of Good’s Syndrome (Immunodeficiency with Thymoma)
23. Inflammatory Linear Verrucous Epidermal Nevus Assessment With in Vivo Reflectance Confocal Microscopy: An Easy Option to Consider
24. Dermatology Publications on COVID-19 during the First Pandemic Year: Creativity or Opportunism?
25. Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study
26. Achievement and maintenance of therapeutic response to brodalumab in patients with moderate‐to‐severe plaque psoriasis: An Italian, observational, retrospective and prospective study (BRIGHT study).
27. Concern about the Effectiveness of mRNA Vaccination Technology and Its Long-Term Safety: Potential Interference on miRNA Machinery
28. Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study
29. MSH peptides and applications to treatment of hair
30. Case series of two different dose regimen Rituximab therapy for severe Pemphigus
31. Sequential treatments of Hailey‐Hailey disease with photodynamic therapy, botulinum toxin type A and dapsone: A case report
32. Atopic Dermatitis: Clinical Aspects and Unmet Needs
33. Real-World Apremilast Use for Treatment of Plaque Psoriasis in Italy: Patient Perspective, Characteristics, and Clinical Outcomes from the DARWIN Study.
34. ESDR475 - Diagnostic potential of circulating extracellular microvesicles in patients with primary and metastatic melanoma
35. ESDR626 - Pulsed Electromagnetic Field and tissue repair: an experimental study on chronic wounds’ fibroblasts
36. National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis
37. "Your Skin Tells You" Campaign for Keratinocyte Cancers: When Individuals' Selection Makes the Difference.
38. Severe non-traumatic bleeding, the answer is not in the blood
39. Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature
40. Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 pandemic. risk analysis from the PSO-BIO-COVID observational study
41. Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry
42. Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasis
43. Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication
44. Effects of Growth Hormone (GH) Supplementation on Dermatoscopic Evolution of Pigmentary Lesions in Children with Growth Hormone Deficiency (GHD)
45. PSORS2 Markers Are Not Associated with Psoriatic Arthritis in the Italian Population
46. EGFR Regulates the Expression of Keratinocyte-Derived Granulocyte/Macrophage Colony-Stimulating Factor In Vitro and In Vivo
47. Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy
48. Risk of infections in psoriasis: assessment and challenges in daily management
49. Mental Health Consequences of the COVID-19 Pandemic Long-Term Exposure in Italian Dermatologists
50. Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.